Ken Fisher’s Quest Diagnostics DGX Stock Holding History

Ken Fisher’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,269	Closed	-$220K	–	1043
2025 Q4	$220K	Buy	+1,269	New	+$231K	﹤0.01%	971
2025 Q3	–	Sell	-1,224	Closed	-$220K	–	1030
2025 Q2	$220K	Sell	1,224 -1,124	-48%	-$195K	﹤0.01%	948
2025 Q1	$397K	Buy	+2,348	New	+$386K	﹤0.01%	837
2023 Q3	–	Sell	-1,504	Closed	-$212K	–	1196
2023 Q2	$212K	Sell	1,504 -117	-7%	-$16.1K	﹤0.01%	1019
2023 Q1	$229K	Buy	+1,621	New	+$232K	﹤0.01%	962

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Ken Fisher's DGX Position: Q1 2026 in Review

Ken Fisher sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,269 shares — an estimated $220K sold.

Ken Fisher first reported a position in DGX in Q1 2023 and held it in 5 quarters. The position peaked at $397K in Q1 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Ken Fisher reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Ken Fisher sold 1,269 Quest Diagnostics shares in Q1 2026, an estimated $220K.
Ken Fisher first reported a position in Quest Diagnostics in Q1 2023 and held it in 5 quarters.
Ken Fisher's Quest Diagnostics position peaked at $397K in Q1 2025.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.